These emerging drugs , including Semaglutide , Mounjaro , and Zaxig , represent a important advancement in addressing type 2 the condition and supporting weight management. They operate by emulating the body’s natural incretin GLP-1 , enabling to moderate blood levels and decrease cravings. The therapy has somewhat unique qualities and might be f